ArticleChild psychiatry and human development2026
Advancing in Personalization of Psychological, Indicated Preventive Interventions: A Randomized Controlled Trial in Adolescents at High-Risk of Developing Emotional Disorders.
Article in Child psychiatry and human development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This randomized controlled trial evaluated the effectiveness of a personalized, transdiagnostic, indicated preventive intervention (PROCARE-I+) compared to its standard format (PROCARE-I) in high-risk adolescents. One hundred and thirty-nine participants were randomized to either a standard transdiagnostic, indicated preventive intervention (PROCARE-I; n = 70) or the personalized intervention with add-on modules (PROCARE-I+; n = 69). Participants were assessed at post-intervention at 6 and 7-month follow-ups (the latter, one month after receiving a booster session). Results showed significant reductions not only in anxiety and depressive symptoms, but also in emotional risk. Improvements in emotion regulation, psychological flexibility, resilience, and quality of life were also found. While both interventions were effective, the personalized PROCARE-I+ intervention revealed greater improvements over time in key outcomes. These findings suggest the potential added value of personalization in transdiagnostic, indicated prevention and its potential to enhance long-term outcomes in adolescents at high risk of developing emotional disorders.
Indexed as
Identifiers
42518027What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.